He Y, Piao Z, Jia Y, Wu H, Wang X, Yu W
Front Neurosci. 2025; 19:1507747.
PMID: 40040846
PMC: 11876162.
DOI: 10.3389/fnins.2025.1507747.
Neiswanger C, Ruiz M, Kimball K, Lee J, Land B, Berndt A
bioRxiv. 2025; .
PMID: 39763910
PMC: 11702588.
DOI: 10.1101/2024.12.16.628727.
Flores-Ramirez F, Illenberger J, Martin-Fardon R
Neurobiol Stress. 2024; 33:100695.
PMID: 39640001
PMC: 11617300.
DOI: 10.1016/j.ynstr.2024.100695.
Estave P, Albertson S, Karkhanis A, Jones S
Sci Rep. 2024; 14(1):6509.
PMID: 38499566
PMC: 10948819.
DOI: 10.1038/s41598-024-53463-9.
Cox B, Toll L
Adv Drug Alcohol Res. 2024; 2:10115.
PMID: 38390618
PMC: 10880772.
DOI: 10.3389/adar.2022.10115.
Oleoylethanolamide attenuates cocaine-primed reinstatement and alters dopaminergic gene expression in the striatum.
Gonzalez-Portilla M, Mellado S, Montagud-Romero S, Rodriguez de Fonseca F, Pascual M, Rodriguez-Arias M
Behav Brain Funct. 2023; 19(1):8.
PMID: 37226219
PMC: 10207629.
DOI: 10.1186/s12993-023-00210-1.
Systemic kappa opioid receptor antagonism accelerates reinforcement learning via augmentation of novelty processing in male mice.
Farahbakhsh Z, Song K, Branthwaite H, Erickson K, Mukerjee S, Nolan S
Neuropsychopharmacology. 2023; 48(6):857-868.
PMID: 36804487
PMC: 10156709.
DOI: 10.1038/s41386-023-01547-x.
Evaluation of the Intracellular Signaling Activities of κ-Opioid Receptor Agonists, Nalfurafine Analogs; Focusing on the Selectivity of G-Protein- and β-Arrestin-Mediated Pathways.
Yamaguchi M, Miyano K, Hirayama S, Karasawa Y, Ohshima K, Uezono E
Molecules. 2022; 27(20).
PMID: 36296658
PMC: 9611050.
DOI: 10.3390/molecules27207065.
Modulation of 5-HT release by dynorphin mediates social deficits during opioid withdrawal.
Pomrenze M, Cardozo Pinto D, Neumann P, Llorach P, Tucciarone J, Morishita W
Neuron. 2022; 110(24):4125-4143.e6.
PMID: 36202097
PMC: 9789200.
DOI: 10.1016/j.neuron.2022.09.024.
Kappa-opioid receptor activation reinstates nicotine self-administration in mice.
Gowrishankar R, Gomez A, Waliki M, Bruchas M
Addict Neurosci. 2022; 2.
PMID: 36118179
PMC: 9481185.
DOI: 10.1016/j.addicn.2022.100017.
Traumatic Stress-Induced Vulnerability to Addiction: Critical Role of the Dynorphin/Kappa Opioid Receptor System.
Leconte C, Mongeau R, Noble F
Front Pharmacol. 2022; 13:856672.
PMID: 35571111
PMC: 9091501.
DOI: 10.3389/fphar.2022.856672.
Effects of Glucagon-Like Peptide-1 Receptor Agonist Exendin-4 on the Reinstatement of Cocaine-Mediated Conditioned Place Preference in Mice.
Zhu C, Wang L, Ding J, Li H, Wan D, Sun Y
Front Behav Neurosci. 2022; 15:769664.
PMID: 35069139
PMC: 8766416.
DOI: 10.3389/fnbeh.2021.769664.
Nicotine and opioid co-dependence: Findings from bench research to clinical trials.
Custodio L, Malone S, Bardo M, Turner J
Neurosci Biobehav Rev. 2021; 134:104507.
PMID: 34968525
PMC: 10986295.
DOI: 10.1016/j.neubiorev.2021.12.030.
Voluntary oral methamphetamine increases memory deficits and contextual sensitization during abstinence associated with decreased PKMζ and increased κOR in the hippocampus of female mice.
Avila J, Memos N, Aslan A, Andrejewski T, Luine V, Serrano P
J Psychopharmacol. 2021; 35(10):1240-1252.
PMID: 34587831
PMC: 9083019.
DOI: 10.1177/02698811211048285.
Stress decreases serotonin tone in the nucleus accumbens in male mice to promote aversion and potentiate cocaine preference via decreased stimulation of 5-HT receptors.
Fontaine H, Silva P, Neiswanger C, Tran R, Abraham A, Land B
Neuropsychopharmacology. 2021; 47(4):891-901.
PMID: 34564712
PMC: 8882182.
DOI: 10.1038/s41386-021-01178-0.
Consideration of sex as a biological variable in the translation of pharmacotherapy for stress-associated drug seeking.
Martin E, Doncheck E, Reichel C, McRae-Clark A
Neurobiol Stress. 2021; 15:100364.
PMID: 34345636
PMC: 8319013.
DOI: 10.1016/j.ynstr.2021.100364.
The Buprenorphine Analogue BU10119 Attenuates Drug-Primed and Stress-Induced Cocaine Reinstatement in Mice.
Hillhouse T, Olson K, Hallahan J, Rysztak L, Sears B, Meurice C
J Pharmacol Exp Ther. 2021; 378(3):287-299.
PMID: 34183434
PMC: 11047085.
DOI: 10.1124/jpet.121.000524.
Neurodevelopmental origins of substance use disorders: Evidence from animal models of early-life adversity and addiction.
Levis S, Baram T, Mahler S
Eur J Neurosci. 2021; 55(9-10):2170-2195.
PMID: 33825217
PMC: 8494863.
DOI: 10.1111/ejn.15223.
Fundamentals of the Dynorphins/Kappa Opioid Receptor System: From Distribution to Signaling and Function.
Cahill C, Tejeda H, Spetea M, Chen C, Liu-Chen L
Handb Exp Pharmacol. 2021; 271:3-21.
PMID: 33754230
PMC: 9013522.
DOI: 10.1007/164_2021_433.
Suicide Risk and Addiction: The Impact of Alcohol and Opioid Use Disorders.
Rizk M, Herzog S, Dugad S, Stanley B
Curr Addict Rep. 2021; 8(2):194-207.
PMID: 33747710
PMC: 7955902.
DOI: 10.1007/s40429-021-00361-z.